Trial intelligence / Profile preview

Antiseptic vaginal preparation for reducing infection morbidity at caesarean section

PACTR202411605053903Completed

Sponsor
Dr oyedeji Oluniyi
Start
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in postpartum infection comparing Povidone-iodine vaginal preparation with Chlorhexidine vaginal preparation (2 arms). Primary endpoint: Reduction in post-caesarean infection morbidity. Started Jul 2023; status: completed.

02

Drugs

povidone-iodinechlorhexidine
03

Conditions

postpartum infection

Beyond the preview

Go deeper on PACTR202411605053903.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202411605053903.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call